Epidemiology of differentiated thyroid carcinoma;Epidemiología del cáncer diferenciado de tiroides

Endocrinologia y Nutricion

Volumn 52, Issue SUPPL. 1, 2005, Pages 2-10

  Lope Carvajal, V ^a   Pollan Santamaria M ^a,b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Epidemiology; Risk factors; Thyroid cancer

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; COWEN DISEASE; DENTIST; DIET; EUROPE; GARDNER SYNDROME; GOITER; HIGH RISK POPULATION; HUMAN; IODINE DEFICIENCY; IONIZING RADIATION; LETHALITY; MALIGNANT NEOPLASTIC DISEASE; OCCUPATIONAL HAZARD; PETROCHEMICAL INDUSTRY; RADIATION EXPOSURE; RADIOACTIVE CONTAMINATION; REVIEW; RISK FACTOR; SPAIN; SYNDROME; TEACHER; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION;

EID: 34547650440     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Ferlay J, Bray F, Sankila R, Parkin DM. EUCAN: cancer incidence, mortality and prevalence in the European Union 1998, version 5.0.IARC.
2. Ron E. Thyroid cancer. En: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press; 1996. p. 1000-21.
3. Berrino F, Capocaccia R, Coleman MP, Esteve J, Gatta G, Hakulinen T, et al. Survival of cancer patients in Europe. The Eurocare-3 Study. Ann Oncology. 2003;14 Suppl 5.
4. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997;79:564-73.
5. Fraker D, Skarulis M, Livolsi V. Thyroid tumors. En: De Vita V, Hellman S, Rosenberg S, editors. Cancer. Principles & practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1740-59.
6. López-Abente G, Pollán M, Aragonés N, Pérez-Gómez B, Hernández V, Lope V, et al. Plan integral del cáncer: situación del cáncer en España. Madrid: Ministerio de Sanidad y Consumo; 2003.
7. Área de Epidemiología Ambiental y Cáncer. Mortalidad por cáncer y otras causas. Disponible en: http://cne.isciii.es
8. Díaz-Cadórniga FJ, Delgado-Álvarez E. Déficit de yodo en España: situación actual. Grupo de Trastornos por Deficiencia en Yodo. Servicio de Endocrinología y Nutrición. Hospital Universitario Central de Asturias. Endocrinol Nutr. 2004;51:2-13.
9. Fincham SM, Ugnat AM, Hill GB, Kreiger N, Mao Y. Is occupation a risk factor for thyroid cancer? Canadian cancer registries epidemiology research group. J Occup Environ Med. 2000;42:318-22.
10. Memon A, Varghese A, Suresh A. Benign thyroid disease and dietary factors in thyroid cancer: a case-control study in Kuwait. Br J Cancer. 2002;86:1745-50.
11. Levi F, Negri E, La Vecchia C, Te VC. Socioeconomic groups and cancer risk at death in the Swiss canton of Vaud. Int J Epidemiol. 1988;17:711-7.
12. Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst. 1977;58:525-47.
13. Levi F, Franceschi S, La Vecchia C, Negri E, Gulie C, Duruz G, et al. Previous thyroid disease and risk of thyroid cancer in Switzerland. Eur J Cancer. 1991;27:85-8.
14. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141:259-77.
15. Duffy BJ Jr, Fitzgerald PJ. Cancer of the thyroid in children: a report of 28 cases. J Clin Endocrinol Metab. 1950;10:1296-308.
16. Hallquist A, Nasman A. Medical diagnostic X-ray radiation - an evaluation from medical records and dentist cards in a case-control study of thyroid cancer in the northern medical region of Sweden. Eur J Cancer Prev. 2001;10:147-52.
17. Takahashi T, Schoemaker MJ, Trott KR, Simon SL, Fujimori K, Nakashima N, et al. The relationship of thyroid cancer with radiation exposure from nuclear weapon testing in the Marshall Islands. J Epidemiol. 2003;13:99-107.
18. Moysich KB, Menezes RJ, Michalek AM. Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol. 2002;3:269-79.
19. Hallquist A, Hardell L, Degerman A, Boquist L. Occupational exposures and thyroid cancer: results of a case-control study. Eur J Cancer Prev. 1993;2:345-9.
20. Carstensen JM, Wingren G, Hatschek T, Fredriksson M, Noorlind-Brage H, Axelson O. Occupational risks of thyroid cancer: data from the Swedish cancer-environment register, 1961-1979. Am J Ind Med. 1990;18:535-40.
21. Wingren GB, Axelson O. Occupational and environmental determinants for benign thyroid disease and follicular thyroid cancer. Int J Occup Environ Health. 1997;3:89-94.
22. Wingren G, Hatschek T, Axelson O. Determinants of papillary cancer of the thyroid. Am J Epidemiol. 1993;138:482-91.
23. Wingren G, Hallquist A, Degerman A, Hardell L. Occupation and female papillary cancer of the thyroid. J Occup Environ Med. 1995;37:294-7.
24. Sont WN, Zielinski JM, Ashmore JP, Jiang H, Krewski D, Fair ME, et al. First analysis of cancer incidence and occupational radiation exposure based on the National dose registry of Canada. Am J Epidemiol. 2001;153:309-18.
25. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles county, 1972-1995. Cancer Causes Control. 2000;11:163-70.
26. Wingren G, Hallquist A, Hardell L. Diagnostic X-ray exposure and female papillary thyroid cancer: a pooled analysis of two Swedish studies. Eur J Cancer Prev. 1997;6:550-6.
27. Reynolds P, Elkin EP, Layefsky ME, Lee GM. Cancer in California school employees, 1988-1992. Am J Ind Med. 1999;36:271-8.
28. Sathiakumar N, Delzell E, Rodu B, Beall C, Myers S. Cancer incidence among employees at a petrochemical research facility. J Occup Environ Med. 2001;43:166-74.
29. Divine BJ, Barron V. Texaco mortality study: III. A cohort study of producing and pipeline workers. Am J Ind Med. 1987;11:189-202.
30. Polednak AP. Thyroid tumors and thyroid function in women exposed to internal and external radiation. J Environ Pathol Toxicol Oncol. 1986;7:53-64.
31. Mallin K, McCann K, D'Aloisio A, Freels S, Piorkowski J, Dimos J, et al. Cohort mortality study of capacitor manufacturing workers, 1944-2000. J Occup Environ Med. 2004;46:565-76.
32. Williams ED, Doniach I, Bjarnason O, Michie W. Thyroid cancer in an iodide rich area: a histopathological study. Cancer. 1977;39:215-22.
33. Pettersson B, Coleman MP, Ron E, Adami HO. Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer. 1996;65:13-9.
34. Huszno B, Szybinski Z, Przybylik-Mazurek E, Stachura J, Trofimiuk M, Buziak-Bereza M, et al. Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area. J Endocrinol Invest. 2003;26 Suppl 2:71-6.
35. Kung TM, Ng WL, Gibson JB. Volcanoes and carcinoma of the thyroid: a possible association. Arch Environ Health. 1981;36:265-7.
36. Spitz MR, Sider JG, Katz RL, Pollack ES, Newell GR. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. Int J Cancer. 1988;42:549-53.
37. Arnbjörnsson E, Arnbjörnsson A, Olafsson A. Thyroid cancer incidence in relation to volcanic activity. Arch Environ Health. 1986;41:36-40.
38. Bosetti C, Negri E, Kolonel L, Ron E, Franceschi S, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables. Cancer Causes Control. 2002;13:765-75.
39. Markaki I, Linos D, Linos A. The influence of dietary patterns on the development of thyroid cancer. Eur J Cancer. 2003;39:1912-9.
40. Bosetti C, Kolonel L, Negri E, Ron E, Franceschi S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control. 2001;12:375-82.
41. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14:773-85.
42. Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control. 1999;10:583-95.
43. From G, Mellemgaard A, Knudsen N, Jorgensen T, Perrild H. Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid. 2000;10:697-700.
44. D'Avanzo B, La Vecchia C, Franceschi S, Negri E, Talamini R. History of thyroid diseases and subsequent thyroid cancer risk. Cancer Epidemiol Biomarkers Prev. 1995;4:193-9.
45. Preston-Martin S, Jin F, Duda MJ, Mack WJ. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control. 1993;4:431-40.
46. Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF, Jr. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987;79:1-12.
47. o 4. Ssecond series. Washington DC: Armed Forces Institute of Pathology; 1969.
48. Robbins SL, Cotram RS, Kumar V. Pathologic basis of disease. Thyroid gland. Philadelphia: WB Saunders; 1984. p. 1201-25.
49. Mori M, Naito M, Watanabe H, Takeichi N, Dohi K, Ito A. Effects of sex difference, gonadectomy, and estrogen on N-methyl-N-nitrosourea induced rat thyroid tumors. Cancer Res. 1990;50:7662-7.
50. Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control. 1999;10:143-55.
51. La Vecchia C, Ron E, Franceschi S, Dal Maso L, Mark SD, Chatenoud L, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control. 1999;10:157-66.
52. Zivaljevic V, Vlajinac H, Jankovic R, Marinkovic J, Dzodic R, Sipeti GS, et al. Case-control study of female thyroid cancer menstrual, reproductive and hormonal factors. Eur J Cancer Prev. 2003;12:63-6.
53. Preston-Martin S, Franceschi S, Ron E, Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control. 2003;14:787-9.
54. Memon A, Darif M, Al Saleh K, Suresh A. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer. 2002;97:82-9.
55. Alsanea O, Clark OH. Familial thyroid cancer. Curr Opin Oncol. 2001;13:44-51.
56. Harach RH. Familial nonmedullary thyroid neoplasia. Endocr Pathol. 2001;12:97-112.
57. Frich L, Glattre E, Akslen LA. Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5,673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomar Prev. 2001;10:113-7.
58. Melillo RM, Cirafici AM, De Falco V, Bellantoni M, Chiappetta G, Fusco A, et al. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol. 2004;165:511-21.
59. Granja F, Morari J, Morari EC, Correa LA, Assumpção LV, Ward LS. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett. 2004;210:151-7.
60. Gaspar J, Rodrigues S, Gil OM, Manita I, Ferreira TC, Limbert E, et al. Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk. Cancer Genet Cytogenet. 2004;151:60-7.
61. Hernández A, Cespedes W, Xamena N, Surralles J, Creus A, Galofre P, et al. Glutathione S-transferase polymorphisms in thyroid cancer patients. Cancer Lett. 2003;190:37-44.
62. Matakidou A, Hamel N, Popat S, Henderson K, Kantemiroff T, Harmer C, et al. Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. Carcinogenesis. 2004;25:369-73.
63. Lesueur F, Corbex M, McKay JD, Lima J, Soares P, Griseri P, et al. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet. 2002;39:260-5.
64. Delzell E, Grufferman S. Cancer and other causes of death among female textile workers, 1976-78. J Natl Cancer Inst. 1983;71:735-40.
65. Wang JX, Boice JD Jr, Li BX, Zhang JY, Fraumeni JF Jr. Cancer among medical diagnostic x-ray workers in China. J Natl Cancer Inst. 1988;80:344-50.
66. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control. 1990;1:223-34.
67. Wingren GB, Axelson O. Occupational and environmental determinants for benign thyroid disease and follicular thyroid cancer. Int J Occup Environ Health. 1997;3:89-94.
68. Robinson CF, Walker JT. Cancer mortality among women employed in fast-growing US occupations. Am J Ind Med. 1999;36:186-92.
69. Fillmore CM, Petralia SA, Dosemeci M. Cancer mortality in women with probable exposure to silica: a death certificate study in 24 states of the US. Am J Ind Med. 1999;36:122-8.